[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Flu Vaccine Market by Manufacturers, States, Type and Application, Forecast to 2022

January 2018 | 122 pages | ID: U7A482097E5EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Scope of the Report:

This report focuses on the Flu Vaccine in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
  • CSL
  • GSK
  • Sanofi Pasteur
  • Mylan
  • AstraZeneca
  • Pfizer
  • Johnson & Johnson
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Market Segment by Type, covers
  • Whole Virus Vaccines
  • Split Virus Vaccines
  • Subunit Vaccines
  • Live Attenuated Virus Vaccines
Market Segment by Applications, can be divided into
  • For Children (6 months to 3 years)
  • For Adults and Children over 3 years
There are 17 Chapters to deeply display the United States Flu Vaccine market.

Chapter 1, to describe Flu Vaccine Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Flu Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Flu Vaccine, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Flu Vaccine market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Flu Vaccine Research Findings and Conclusion, Appendix, methodology and data source.
1 MARKET OVERVIEW

1.1 Flu Vaccine Introduction
1.2 Market Analysis by Type
  1.2.1 Whole Virus Vaccines
  1.2.2 Split Virus Vaccines
  1.2.3 Subunit Vaccines
  1.2.4 Live Attenuated Virus Vaccines
1.3 Market Analysis by Applications
  1.3.1 For Children (6 months to 3 years)
  1.3.2 For Adults and Children over 3 years
1.4 Market Analysis by States
  1.4.1 California Status and Prospect (2012-2022)
  1.4.2 Texas Status and Prospect (2012-2022)
  1.4.3 New York Status and Prospect (2012-2022)
  1.4.4 Florida Status and Prospect (2012-2022)
  1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 CSL
  2.1.1 Profile
  2.1.2 Flu Vaccine Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 CSL News
2.2 GSK
  2.2.1 Profile
  2.2.2 Flu Vaccine Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 GSK News
2.3 Sanofi Pasteur
  2.3.1 Profile
  2.3.2 Flu Vaccine Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Sanofi Pasteur News
2.4 Mylan
  2.4.1 Profile
  2.4.2 Flu Vaccine Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Mylan News
2.5 AstraZeneca
  2.5.1 Profile
  2.5.2 Flu Vaccine Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 AstraZeneca News
2.6 Pfizer
  2.6.1 Profile
  2.6.2 Flu Vaccine Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Pfizer News
2.7 Johnson & Johnson
  2.7.1 Profile
  2.7.2 Flu Vaccine Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Johnson & Johnson News

3 UNITED STATES FLU VACCINE MARKET COMPETITION, BY MANUFACTURER

3.1 United States Flu Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Flu Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Flu Vaccine Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Flu Vaccine Manufacturer Market Share
  3.4.2 Top 5 Flu Vaccine Manufacturer Market Share
3.5 Market Competition Trend

4 UNITED STATES FLU VACCINE MARKET ANALYSIS BY STATES

4.1 United States Flu Vaccine Sales Market Share by States
4.2 United States Flu Vaccine Sales by States (2012-2017)
4.3 United States Flu Vaccine Revenue (Value) by States (2012-2017)

5 UNITED STATES MARKET SEGMENTATION FLU VACCINE BY TYPE

5.1 United States Flu Vaccine Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 United States Flu Vaccine Sales and Market Share by Type (2012-2017)
  5.1.2 United States Flu Vaccine Revenue and Market Share by Type (2012-2017)
5.2 Whole Virus Vaccines Sales Growth and Price
  5.2.1 United States Whole Virus Vaccines Sales Growth (2012-2017)
  5.2.2 United States Whole Virus Vaccines Price (2012-2017)
5.3 Split Virus Vaccines Sales Growth and Price
  5.3.1 United States Split Virus Vaccines Sales Growth (2012-2017)
  5.3.2 United States Split Virus Vaccines Price (2012-2017)
5.4 Subunit Vaccines Sales Growth and Price
  5.4.1 United States Subunit Vaccines Sales Growth (2012-2017)
  5.4.2 United States Subunit Vaccines Price (2012-2017)
5.5 Live Attenuated Virus Vaccines Sales Growth and Price
  5.5.1 United States Live Attenuated Virus Vaccines Sales Growth (2012-2017)
  5.5.2 United States Live Attenuated Virus Vaccines Price (2012-2017)

6 UNITED STATES MARKET SEGMENTATION FLU VACCINE BY APPLICATION

6.1 United States Flu Vaccine Sales Market Share by Application (2012-2017)
6.2 For Children (6 months to 3 years) Sales Growth (2012-2017)
6.3 For Adults and Children over 3 years Sales Growth (2012-2017)

7 CALIFORNIA FLU VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 California Flu Vaccine Revenue, Sales and Growth Rate (2012-2017)
7.2 California Flu Vaccine Sales and Market Share by Type
7.3 California Flu Vaccine Sales by Application (2012-2017)

8 NEW YORK FLU VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 New York Flu Vaccine Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Flu Vaccine Sales and Market Share by Type
8.3 New York Flu Vaccine Sales by Application (2012-2017)

9 TEXAS FLU VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Texas Flu Vaccine Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Flu Vaccine Sales and Market Share by Type
9.3 Texas Flu Vaccine Sales by Application (2012-2017)

10 FLORIDA FLU VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Florida Flu Vaccine Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Flu Vaccine Sales and Market Share by Type
10.3 Florida Flu Vaccine Sales by Application (2012-2017)

11 ILLINOIS FLU VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Illinois Flu Vaccine Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Flu Vaccine Sales and Market Share by Type
11.3 Illinois Flu Vaccine Sales by Application (2012-2017)

12 FLU VACCINE MARKET FORECAST (2017-2022)

12.1 United States Flu Vaccine Sales, Revenue and Growth Rate (2017-2022)
12.2 Flu Vaccine Market Forecast by States (2017-2022)
12.3 Flu Vaccine Market Forecast by Type (2017-2022)
12.4 Flu Vaccine Market Forecast by Application (2017-2022)

13 FLU VACCINE MANUFACTURING COST ANALYSIS

13.1 Flu Vaccine Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Flu Vaccine

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Flu Vaccine Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Flu Vaccine Major Manufacturers in 2016
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source
LIST OF TABLES AND FIGURES

Figure Flu Vaccine Picture
Table Product Specifications of Flu Vaccine
Figure United States Sales Market Share of Flu Vaccine by Types in 2016
Table Types of Flu Vaccine
Figure Whole Virus Vaccines Picture
Table Major Manufacturers of Whole Virus Vaccines
Figure Split Virus Vaccines Picture
Table Major Manufacturers of Split Virus Vaccines
Figure Subunit Vaccines Picture
Table Major Manufacturers of Subunit Vaccines
Figure Live Attenuated Virus Vaccines Picture
Table Major Manufacturers of Live Attenuated Virus Vaccines
Table United States Flu Vaccine Sales Market Share by Applications in 2016
Table Applications of Flu Vaccine
Figure For Children (6 months to 3 years) Picture
Figure For Adults and Children over 3 years Picture
Figure California Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Flu Vaccine Type and Applications
Table CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Flu Vaccine Type and Applications
Table GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table Sanofi Pasteur Flu Vaccine Type and Applications
Table Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Flu Vaccine Type and Applications
Table Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Flu Vaccine Type and Applications
Table AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Flu Vaccine Type and Applications
Table Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Flu Vaccine Type and Applications
Table Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Flu Vaccine Sales by Manufacturer (2016-2017)
Figure United States Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure United States Flu Vaccine Sales Market Share by Manufacturer in 2017
Table United States Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure United States Flu Vaccine Revenue Market Share by Manufacturer in 2015
Figure United States Flu Vaccine Revenue Market Share by Manufacturer in 2016
Table United States Flu Vaccine Price by Manufacturers (2016-2017)
Figure Top 3 Flu Vaccine Manufacturer Market Share in 2016
Figure Top 3 Flu Vaccine Manufacturer Market Share in 2017
Figure Top 5 Flu Vaccine Manufacturer Market Share in 2016
Figure Top 5 Flu Vaccine Manufacturer Market Share in 2017
Figure United States Flu Vaccine Sales and Growth (2012-2017)
Table United States Flu Vaccine Sales by States (2012-2017)
Table United States Flu Vaccine Sales Market Share by States (2012-2017)
Figure United States 2012 Flu Vaccine Sales Market Share by States
Figure United States 2016 Flu Vaccine Sales Market Share by States
Figure United States Flu Vaccine Revenue and Growth (2012-2017)
Table United States Flu Vaccine Revenue by States (2012-2017)
Table United States Flu Vaccine Revenue Market Share by States (2012-2017)
Table United States 2012 Flu Vaccine Revenue Market Share by States
Table United States 2016 Flu Vaccine Revenue Market Share by States
Table United States Flu Vaccine Sales by Type (2012-2017)
Table United States Flu Vaccine Sales Share by Type (2012-2017)
Table United States Flu Vaccine Revenue by Type (2012-2017)
Table United States Flu Vaccine Revenue Share by Type (2012-2017)
Figure United States Whole Virus Vaccines Sales Growth (2012-2017)
Figure United States Whole Virus Vaccines Price (2012-2017)
Figure United States Split Virus Vaccines Sales Growth (2012-2017)
Figure United States Split Virus Vaccines Price (2012-2017)
Figure United States Subunit Vaccines Sales Growth (2012-2017)
Figure United States Subunit Vaccines Price (2012-2017)
Figure United States Live Attenuated Virus Vaccines Sales Growth (2012-2017)
Figure United States Live Attenuated Virus Vaccines Price (2012-2017)
Table United States Flu Vaccine Sales by Application (2012-2017)
Table United States Flu Vaccine Sales Share by Application (2012-2017)
Figure United States For Children (6 months to 3 years) Sales Growth (2012-2017)
Figure United States For Adults and Children over 3 years Sales Growth (2012-2017)
Figure California Flu Vaccine Revenue and Growth (2012-2017)
Figure California Flu Vaccine Sales and Growth (2012-2017)
Table California Flu Vaccine Sales by Type (2012-2017)
Table California Flu Vaccine Sales Market Share by Type (2012-2017)
Table California Flu Vaccine Sales by Application (2012-2017)
Table California Flu Vaccine Sales Market Share by Application (2012-2017)
Figure New York Flu Vaccine Revenue and Growth (2012-2017)
Figure New York Flu Vaccine Sales and Growth (2012-2017)
Table New York Flu Vaccine Sales by Type (2012-2017)
Table New York Flu Vaccine Sales Market Share by Type (2012-2017)
Table New York Flu Vaccine Sales by Application (2012-2017)
Table New York Flu Vaccine Sales Market Share by Application (2012-2017)
Figure Texas Flu Vaccine Revenue and Growth (2012-2017)
Figure Texas Flu Vaccine Sales and Growth (2012-2017)
Table Texas Flu Vaccine Sales by Type (2012-2017)
Table Texas Flu Vaccine Sales Market Share by Type (2012-2017)
Table Texas Flu Vaccine Sales by Application (2012-2017)
Table Texas Flu Vaccine Sales Market Share by Application (2012-2017)
Figure Florida Flu Vaccine Revenue and Growth (2012-2017)
Figure Florida Flu Vaccine Sales and Growth (2012-2017)
Table Florida Flu Vaccine Sales by Type (2012-2017)
Table Florida Flu Vaccine Sales Market Share by Type (2012-2017)
Table Florida Flu Vaccine Sales by Application (2012-2017)
Table Florida Flu Vaccine Sales Market Share by Application (2012-2017)
Figure Illinois Flu Vaccine Revenue and Growth (2012-2017)
Figure Illinois Flu Vaccine Sales and Growth (2012-2017)
Table Illinois Flu Vaccine Sales by Type (2012-2017)
Table Illinois Flu Vaccine Sales Market Share by Type (2012-2017)
Table Illinois Flu Vaccine Sales by Application (2012-2017)
Table Illinois Flu Vaccine Sales Market Share by Application (2012-2017)
Figure United States Flu Vaccine Sales, Revenue and Growth Rate (2017-2022)
Table United States Flu Vaccine Sales Forecast by States (2017-2022)
Table United States Flu Vaccine Market Share Forecast by States (2017-2022)
Table United States Flu Vaccine Sales Forecast by Type (2017-2022)
Table United States Flu Vaccine Market Share Forecast by Type (2017-2022)
Table United States Flu Vaccine Sales Forecast by Application (2017-2022)
Table United States Flu Vaccine Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Flu Vaccine
Figure Manufacturing Process Analysis of Flu Vaccine
Figure Flu Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Flu Vaccine Major Manufacturers in 2016
Table Major Buyers of Flu Vaccine
Table Distributors/Traders/ Dealers List


More Publications